Type 2 Diabetes Trial, Recruiting NCT06600724 Sponsor: MiMedx Group, Inc. Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06600724
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with type 1 or type 2 diabetes.
  • Your foot ulcer measures between 0.7 cm² and 5.0 cm² after being cleaned and prepared by a medical professional.
  • Your foot ulcer has been present for at least 4 weeks but no longer than 52 weeks before your first screening visit.
  • Your ulcer is located on the foot, with at least half of it below the ankle bone.
  • Your ulcer goes through the skin into deeper tissue but does not expose any tendon or bone (confirm with trial site for exact grading).
  • A test done within the last 3 months shows that blood is flowing adequately to the affected leg and foot (confirm with trial site for which test applies to you).
  • If you have more than one ulcer, they must be at least 2 cm apart, and the largest qualifying one will be the focus of the study.
  • If your ulcer is on the bottom of your foot, it must have been properly offloaded (pressure relieved) for at least 14 days before joining.
  • You are willing to use the prescribed pressure-relief method (such as a special boot or cast) for the entire study.
  • You are able and willing to attend weekly study visits.
  • You are able to understand and agree to the consent process.

Who may not be able to join:

  • Your life expectancy is expected to be less than 6 months.
  • Your foot ulcer is not caused by diabetes.
  • Your ulcer is currently infected, or the surrounding skin shows signs of infection (redness, swelling spreading from the wound).
  • Your ulcer exposes tendon or bone.
  • There is evidence of a bone infection related to the ulcer.
  • You have an infection in the ulcer or elsewhere in your body that requires antibiotic treatment taken by mouth or through an IV.
  • You are taking medications that suppress your immune system, such as high-dose steroids, chemotherapy, or certain biologic drugs (confirm with trial site).
  • You are currently taking a medication called hydroxyurea.
  • You have applied steroid creams or ointments directly to the ulcer within the past month.
  • You have had a partial amputation on the affected foot that makes it difficult to properly relieve pressure on the ulcer.
  • Your recent blood sugar control test (HbA1c) showed a result of 12% or higher within the past 3 months.
  • Your ulcer has already shrunk by more than 20% in the 2 weeks before your first screening visit.
  • Your ulcer shrinks by 20% or more during the 2-week screening period before the study begins.
  • You have an active or inactive Charcot foot condition that makes proper pressure relief difficult (confirm with trial site).
  • You are pregnant or planning to become pregnant within the next 6 months.
  • You have end-stage kidney disease and require dialysis.
  • You have taken part in another clinical trial using an experimental treatment within the last 30 days.
  • You have a medical or psychological condition that the study doctor believes could interfere with the study (confirm with trial site).
  • You have received hyperbaric oxygen therapy or a special wound-healing skin product within the 30 days before your first screening visit.
  • Your nutritional assessment score indicates significant malnutrition (confirm with trial site).
  • Your wound has an active or hidden infection.
  • You have a condition that would create an unacceptable risk of complications from any procedures involved in the study (confirm with trial site).
  • You have a known allergy to a type of antibiotic called aminoglycosides.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
MiMedx Group, Inc.
Registry
ClinicalTrials.gov
Start date
27 August 2024
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of target ulcers achieving wound closure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov